Healios KK Company Top Insiders
| HLOSF Stock | USD 1.93 0.38 16.45% |
Healios KK employs about 116 people. The company is managed by 8 executives with a total tenure of roughly 271 years, averaging almost 33.0 years of service per executive, having 14.5 employees per reported executive. Examination of Healios KK's management performance can provide insight into the company performance.
| Richard Kincaid Insider Ex CFO |
| Koji Abe Insider Ex Officer |
Healios |
Healios KK Management Team Effectiveness
The company has return on total asset (ROA) of (0.1712) % which means that it has lost $0.1712 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6829) %, meaning that it generated substantial loss on money invested by shareholders. Healios KK's management efficiency ratios could be used to measure how well Healios KK manages its routine affairs as well as how well it operates its assets and liabilities.Healios KK Workforce Comparison
Healios KK is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 4,252. Healios KK holds roughly 116 in number of employees claiming about 2.73% of stocks in Biotechnology industry.
Healios KK Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Healios KK Price Series Summation is a cross summation of Healios KK price series and its benchmark/peer.
Healios KK Notable Stakeholders
A Healios KK stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Healios KK often face trade-offs trying to please all of them. Healios KK's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Healios KK's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Richard Kincaid | Ex CFO | Profile | |
| Koji Abe | Ex Officer | Profile | |
| Junichi Kotera | Ex Manufacturing | Profile | |
| Masanori Sawada | Exec Officer | Profile | |
| Kouichi Tamura | Ex Institute | Profile | |
| Michihisa Nishiyama | Ex Officer | Profile | |
| Yoshinari Matsuda | MD Director | Profile | |
| Tadahisa MD | Chairman CEO | Profile |
About Healios KK Management Performance
The success or failure of an entity such as Healios KK often depends on how effective the management is. Healios KK management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Healios management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Healios management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan. Healios K is traded on OTC Exchange in the United States.
Healios KK Workforce Analysis
Traditionally, organizations such as Healios KK use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Healios KK within its industry.Healios KK Manpower Efficiency
Return on Healios KK Manpower
| Revenue Per Employee | 353.4K | |
| Revenue Per Executive | 5.1M | |
| Net Loss Per Employee | 42.3M | |
| Net Loss Per Executive | 613.8M | |
| Working Capital Per Employee | 1.2K | |
| Working Capital Per Executive | 17K |
Complementary Tools for Healios Pink Sheet analysis
When running Healios KK's price analysis, check to measure Healios KK's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healios KK is operating at the current time. Most of Healios KK's value examination focuses on studying past and present price action to predict the probability of Healios KK's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healios KK's price. Additionally, you may evaluate how the addition of Healios KK to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |